Refine by
Drug Candidate Articles & Analysis
245 news found
Conducted in accordance with OECD Guidelines for Testing of Chemicals, Test No. 471, the bacterial reverse mutation test (Ames) uses histidine-dependent strains of Salmonella typhimurium or Escherichia coli to detect permanent gene mutations (e.g., single or multiple base pair substitutions, insertions or deletions) caused by new chemicals and candidate drugs. To ...
BySTEMart
Through this program, investigators or technology transfer offices with potential oncology drug candidates, in the early discovery or development phases, can submit their application to POAI for consideration. The POAI platform provides data (wet lab and active ML modeling) back to researchers based on access to an otherwise unreachable number of primary patient ...
Their impact is so great that safe and effective antiviral drugs have become an important tool in the fight against viral infections. ...
” The models are designed for flexibility and can be tailored to accommodate specific research needs, including the ability to test various drug candidates, dietary influences, and lifestyle interventions in a controlled environment. ...
The platform developed by Protheragen-ING AI-Pharma is a revolutionary step forward in the identification and optimization of drug candidates. The traditional process of drug discovery is notoriously lengthy and resource-intensive, often requiring extensive experimental trials and significant manual analysis. ...
Idiopathic pulmonary fibrosis (IPF) is a devastating disease characterized by progressive scarring of the lungs, which severely impairs lung function over time. Developing effective treatments for IPF has been a challenge for the medical community, as the mechanisms driving this disease are complex and not fully understood. To accelerate drug discovery, animal models that closely mimic the ...
The process of antipsychiatric drug development typically involves several stages, including identifying potential drug targets, conducting preclinical research to test the safety and efficacy of potential drug candidates, and then moving on to clinical trials to further evaluate the drug’s effectiveness ...
This process is divided into virtual screening based on molecular docking and virtual screening based on pharmacophore, allowing for the efficient identification of promising drug candidates. In addition to forward screening, CD ComputaBio also offers reverse screening services, enabling the identification of potential drug targets for ...
CanaQuest Medical Corp (“CanaQuest” or the “Company”) (OTC: CANQF), is pleased to announce strategic additions to its executive team with expertise in conducting clinical trials and US FDA drug approval success. The team plans to effectively navigate the regulatory approval process for Drug Candidate, CQ-001 (cannabidiol + ...
Small molecules play a crucial role in modern drug discovery and development. They are typically organic compounds with a low molecular weight that can easily penetrate cell membranes, making them ideal candidates for targeting intracellular pathways and interacting with specific proteins or enzymes. Small molecule drugs have a proven track ...
STEMart, a US-based provider of comprehensive services for all phases of medical device development, announced the launch of its new Force Degradation Services to help pharmaceutical and medical device companies evaluate the stability of their drug candidates and finished products under a variety of stress conditions, ensuring their safety and efficacy throughout ...
BySTEMart
NHL Alumni Association (NHLAA), NEEKA Health Canada("NEEKA"),and CanaQuest Medical Corp ("CanaQuest") are pleased to announce a transformative study partnership that will investigate the efficacy of Mentanine® as a potential treatment to reduce anxiety in former NHL ...
DYANAVEL XR is a federally controlled substance (CII) because it contains amphetamine that can be a target for people who abuse prescription medicines or street drugs. Keep DYANAVEL XR in a safe place to protect it from theft. Never give your DYANAVEL XR to anyone else because it may cause death or harm them. ...
At present, anxiety and depression-related animal behavior tests are widely used in pharmacological research to evaluate the characteristics of candidate drugs for treating these diseases in rodent models. These tests can provide valuable insights into the potential clinical applications of compounds. ...
” About Tris Pharma Tris Pharma is a privately held, innovation-driven biopharmaceutical company that is applying its drug development capabilities and proprietary technologies to transform the treatment of ADHD, pain and neurological disorders, including addiction and diseases of the central nervous system. Tris is an established commercial organization with a robust ...
CanaQuest Medical Corp ("CanaQuest" or the "Company") (OTC:CANQF), a clinical-stage life sciences company focused on drug discovery and development of next-generation targeted cannabinoid therapeutics for the central nervous system (CNS), is pleased to announce it was awarded a European Cannabinoid Patent, a novel Botanical and Tetrahydrocannabinol ("THC") Formulation for the ...
Key secondary endpoints included “overall drug liking” and “take drug again” scores measured by the VAS. ...
Our team recognizes this need and has developed a suite of services to support drug development at its earliest stages. With cutting-edge technology and superior expertise, our highly skilled scientists are very pleased to provide valuable insights into the safety and effectiveness of potential drug candidates,” said the Marketing Chief of ...
This approach is poised to revolutionize the field of drug discovery by offering researchers an efficient and cost-effective solution for identifying promising drug candidates. ...
Canaquest Medical Corp (OTC PINK:CANQF) (the "Company" or "CanaQuest"), a clinical-stage life sciences company focused on drug discovery and development of next-generation targeted cannabinoid therapeutics for the central nervous system (CNS), today announced that it has been awarded the Best Global Medical Cannabinoid Development Company 2023, in its eighth annual Healthcare and Pharmaceutical ...